Following the discovery of CD5 as a β-glucan PRR, CD5-deficient (cd5−/−) mice demonstrated higher susceptibility to systemic fungal (i.e., Candida albicans and Cryptococus neoformans) infection concomitant with lower pro-inflammatory cytokine production and T and B cell activation [54]. The gene discussed is CD5; the disease is infection.